Company Overview
Sanofi-aventis is facing the future and leading the way as the 3rd largest pharmaceutical company in the world and number 1 in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine, and vaccines.Embrace this opportunity to join a diverse and talented group of individuals championed to take on innovation and change in our rapidly expanding organization.
Job Description
Sanofi-aventis is facing the future and leading the way as the 3rd largest pharmaceutical company in the world and number 1 in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine, and vaccines.
Embrace this opportunity to join a diverse and talented group of individuals championed to take on innovation and change in our rapidly expanding organization.
Job Summary:
This position serve as evidence generation expert to define the protocols, synopses & syntheses of comparative effectiveness and health outcomes studies to support R&D product development from early to late phases. The position will serve as methodological expert as well as effective communicator in evidence generation functions thru evidence-based synthesis and definition of comparative or relative effectiveness research, participation in internal and external forums on CER methodology, development and implementation of patient reported outcomes studies, conducting literature review and economic modeling, prodviding support for RCT design, by sustained engagement and coordination with matrix partners and affiliate countries in development and implementation of health outcomes research studies.
Major Duties & Responsibilities:
Assist in developing and establishing a global strategic framework for comparative effectiveness and health outcomes programs including real world retrospective and prospective research programs, economic modeling, and patient reported outcomes assessments.
Collaborate with all stakeholders, internal and external experts to systematically develop, validate, interpret, and communicate value evidence for R&D portfolio
Guide, develop and implement scientific programs or research agenda relevant to real world evidence generation for comparative effectiveness and health outcomes
Be responsible for integrated evidence generation reports for selected therapeutics areas across evidence generation functional teams
Effectively coordinate and priortize projects across matrix function teams including evidence-based medicine, clinical trials, quantitative sciences, real world data analytics and evidence translations.
Assessing the integrated evidence for gaps and opportunities for development of evidence for the value proposition of a product
Prioritize and implement tactical planning for comparative evidence generation and outcomes evaluation in supporting key management decision making and business and medical strategies
Assist in communicating the systematic approach to CER and in scientific publications and presentations related to comparative effectiveness
Support the team leader to develop and establish a global strategic framework for comparative effectiveness and health outcomes programs including real world retrospective research programs by helping in activities such as SOP development and process innovation.
Articulate scientific hypotheses, integrate the data to support hypothesis testing for product priorities and present the big picture from the quantitative evidence coming from different sources
Major Challenges & Problems:
The incumbent of this position will collaborate with evidence generation and translation teams to identify efficient and effective data capabilities and partnership to advance the team deliverables and achieve innovative team objectives
Key Internal/External Relationships:
Promote interactions, communications and collaborations in the matrix organization and evidence based, two-way dialogue with stakeholders
View the Original article
No comments:
Post a Comment